Skip to main content
. 2022 Feb 10;9(1):8–13. doi: 10.14744/nci.2021.08634

Table 2.

Univariate analysis of the factors associated with medication non-adherence

Adherent Non-adherent p
Age* 48±13 41±12 0.039
Gender (%) 1.00
 Female 52.0 51.7
 Male 48.0 48.3
Travel distance to
outpatient clinic (km)**
49 10
Travel time to outpatient clinic (km)**
Duration of disease (years)** 4.5 6 0.025
Smoking status (%) 0.412
 Non-smoker 42.7 31. 0
 Former smoker 26.7 31.0
 Current smoker 30.7 37.9
Outpatient visit last year (%)
Changed residency 94.6 89.7 0.334
Transport to hospital (%) 1.00
 Own car 50.7 49.1
 Public transport 32.9 33.3
 Both 16.4 17.5
Medication (%)
 ASA 92.0 93.1 1.00
 Budesonide 47.3 45.6 0.86
 Azathioprine 68.9 54.4 0.128
Anti-TNF (%)
 Adalimumab 18.7 13.8 0.607
 Infliximab 9.3 16.1 0.371
Education (%) 0.023
 Low¥ 56.0 35.7
 High§ 44.0 64.3
Household Income (%) 0.972
 Low 40.5 38.6
 Moderate 45.9 47.4
 High 13.5 14.0
Crohn’s disease behavior (%) 0.609
 Complicated 17.3 22.4
 Not complicated 82.7 77.6
Disease activity (%) 0.999
 Active 34.7 36.2
 Remission 65.3 63.8

*: Mean±SD; **: Median; km: Kilometer; ¥: Education levels lower than high school degree; §: University and college degree; SD: Standard deviation; ASA: American Society of Anesthesiologist; SD: Standard deviation.